Tenet Healthcare Corp Stock Price, News & Analysis

Tenet Healthcare (NYSE: THC) priced a private offering upsized to $2.25 billion of notes on November 3, 2025: $1.5 billion 5.500% senior secured first lien notes due November 15, 2032 and $0.75 billion 6.000% senior notes due November 15, 2033.

Closing is expected on November 18, 2025. Net proceeds, with cash on hand, will redeem all $1.5 billion outstanding 6.250% second lien notes due February 2027 and partially redeem $0.75 billion of 6.125% senior notes due October 2028. First lien notes are secured; senior notes are unsecured and will be offered only to qualified institutional buyers or outside U.S. persons under Regulation S.

Tenet Healthcare (NYSE: THC) announced private placements of $1.5 billion of senior secured first lien notes due 2032 and $0.5 billion of senior notes due 2033 to refinance $2.0 billion of outstanding notes.

The first lien notes will be guaranteed by certain subsidiaries and secured by a pledge of subsidiary ownership interests; the senior notes will be unsecured and structurally subordinated to subsidiary liabilities. Offerings are private to QIBs and non-U.S. persons under Rule 144A and Regulation S and are subject to pricing and customary closing conditions.

Tenet (NYSE: THC) reported third-quarter 2025 results with Q3 net income $342M ($3.86 diluted) and Adjusted diluted EPS $3.70, up 26.3% year-over-year. Consolidated Adjusted EBITDA was $1.099B, up 12.4% versus Q3 2024; Ambulatory Adjusted EBITDA was $492M, up 12.1%.

Year-to-date free cash flow was $2.163B, operating cash flow $2.809B, and net debt/Adjusted EBITDA improved to 2.30x. Tenet repurchased 0.6M shares for $93M in Q3 and 7.8M shares for $1.188B year-to-date. Management raised FY 2025 Adjusted EBITDA outlook to $4.47B–$4.57B (midpoint +$50M).

Tenet Healthcare (NYSE:THC) has scheduled the release of its Q3 2025 financial results for Tuesday, October 28, 2025, before market opening. The company will host a conference call at 9:30 a.m. CT (10:30 a.m. ET) to discuss the results. Investors can access both the live webcast and audio archive through Tenet's investor relations website.

Tenet Healthcare (NYSE:THC) announced its upcoming participation in the 2025 Wells Fargo Healthcare Conference. The presentation is scheduled for September 3, 2025, at 9:30 a.m. Eastern Time.

Investors can access the live webcast and audio archive through Tenet's investor relations website. The replay will remain available for 30 days following the presentation.

Tenet Healthcare (NYSE:THC) and its subsidiary USPI have been named foundational sponsors of the American Association of Orthopaedic Surgeons' (AAOS) inaugural Launchpad Program. The 20-month initiative is designed to support postgraduate year 5 (PGY5) orthopaedic surgery residents in their transition from residency to practice.

The program, launched as a pilot at the AAOS Annual Meeting in March 2025, will support three cohorts of PGY5 resident members over the next three and a half years. It focuses on fellowship navigation, preparation for American Board of Orthopaedic Surgery examinations, and building foundations for long-term success. AAOS plans to expand the program to include all PGY4 and PGY5 residents after the pilot phase.

Tenet Healthcare (NYSE:THC) reported strong Q2 2025 results with significant growth across key metrics. Net income reached $288 million ($3.14 per diluted share), while Adjusted EBITDA increased 18.6% to $1.121 billion with a 21.3% margin.

The company's Ambulatory Care segment showed robust performance with Adjusted EBITDA of $498 million, up 11.4% year-over-year. The Hospital segment delivered strong results with Adjusted EBITDA of $623 million, benefiting from favorable payer mix and higher acuity services.

Notably, the Board authorized a $1.5 billion increase to the share repurchase program. Tenet raised its FY 2025 outlook, now expecting Adjusted EBITDA between $4.40-$4.54 billion, a $395 million increase at the midpoint.

Tenet Healthcare (NYSE: THC) has announced it will release its Q2 2025 financial results on Tuesday, July 22nd, 2025, before market opening. Following the earnings release, the company will host a conference call at 9:00 a.m. Central Time (10:00 a.m. Eastern Time) to discuss the results. Investors and interested parties can access the live webcast and audio archive of the earnings call through Tenet's investor relations website at www.tenethealth.com/investors.

Tenet Healthcare Corporation (NYSE: THC) has announced its participation in the upcoming BofA Securities 2025 Health Care Conference. The company's presentation is scheduled for Tuesday, May 13, 2025, at 1:40 p.m. Eastern time. Investors and interested parties can access the live webcast through Tenet's investor relations website at www.tenethealth.com/investors. A replay of the presentation will remain available on the website for 30 days following the event.